Where does your next new patient start come from?
Reach prescribers where decisions are actually made — inside the EHR and e-prescribing workflows.
Why Access — Not Supply — Stymies Endemic Investment
The reason isn’t a lack of inventory. It’s a lack of proof. Brands can’t demonstrate they reached the prescriber who matters, at the moment that matters. Existing channels sell impressions. Lane4.io sells access — to the clinical moment where brand preference converts to a prescription.